U.S. flag

An official website of the United States government

NM_000454.5(SOD1):c.143T>C (p.Val48Ala) AND Amyotrophic lateral sclerosis type 1

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 11, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001318269.6

Allele description

NM_000454.5(SOD1):c.143T>C (p.Val48Ala)

Gene:
SOD1:superoxide dismutase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
21q22.11
Genomic location:
Preferred name:
NM_000454.5(SOD1):c.143T>C (p.Val48Ala)
HGVS:
  • NC_000021.9:g.31663860T>C
  • NG_008689.1:g.9239T>C
  • NM_000454.5:c.143T>CMANE SELECT
  • NP_000445.1:p.Val48Ala
  • LRG_652:g.9239T>C
  • NC_000021.8:g.33036173T>C
Protein change:
V48A
Links:
dbSNP: rs1568809169
NCBI 1000 Genomes Browser:
rs1568809169
Molecular consequence:
  • NM_000454.5:c.143T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Amyotrophic lateral sclerosis type 1 (ALS1)
Synonyms:
AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL
Identifiers:
MONDO: MONDO:0007103; MedGen: C1862939; Orphanet: 803; OMIM: 105400

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001508966Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Dec 11, 2023)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history.

Tang L, Ma Y, Liu XL, Chen L, Fan DS.

Transl Neurodegener. 2019;8:2. doi: 10.1186/s40035-018-0142-8. Erratum in: Transl Neurodegener. 2019 Mar 19;8:10. doi: 10.1186/s40035-019-0150-3.

PubMed [citation]
PMID:
30637102
PMCID:
PMC6325854

Clinical and genetic features of patients with amyotrophic lateral sclerosis in southern China.

Chen W, Xie Y, Zheng M, Lin J, Huang P, Pei Z, Yao X.

Eur J Neurol. 2020 Jun;27(6):1017-1022. doi: 10.1111/ene.14213. Epub 2020 Apr 10.

PubMed [citation]
PMID:
32166880
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV001508966.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

This sequence change replaces valine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 48 of the SOD1 protein (p.Val48Ala). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant amyotrophic lateral sclerosis (PMID: 30637102, 32166880, 34404558). ClinVar contains an entry for this variant (Variation ID: 1018905). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SOD1 protein function with a positive predictive value of 95%. This variant disrupts the p.Val48 amino acid residue in SOD1. Other variant(s) that disrupt this residue have been observed in individuals with SOD1-related conditions (PMID: 25729540), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024